Healthcare >> CEO Interviews >> February 19, 2001
DR. TSVI GOLDENBERG has been serving as Immusol's Chairman of the Board
and Chief Executive Officer since April 1994. From October 1986 through
April 1994, Dr. Goldenberg served as Vice President of Research and
Development at Advanced Interventional Systems, a vascular disease
products company, with primary responsibility for clinical trials.
Beginning in 1981, Dr. Goldenberg founded and managed a series of
companies involved in the diagnosis and therapy of cardiovascular
diseases, including the use of digital subtraction angiography in
interventional radiology. He served as a Research Scientist in
Interventional Cardiology at Cedars Sinai Medical Center from 1984-1990.
Dr. Goldenberg received a BS from the Israel Institute of Technology and
a PhD from Ohio State University. Profile
Immusol, Incorporated?
Dr. Goldenberg: Immusol, Inc. is a privately held, biopharmaceutical
company located in San Diego. We
